ArticleVirology journal2025
An automatic NGS feature extraction algorithm for predicting EBV-associated nasopharyngeal cancer and high-risk mutation.
Article in Virology journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Integrative analysis of tumor-educated platelets for stage-specific diagnosis, prognosis, and therapy in ovarian cancer.Discover oncology · 2026Article
- Therapeutic Innovations in Nasopharyngeal Carcinoma: Current Strategies and Emerging Perspectives.Life (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
Epstein-Barr virus (EBV) infection is closely associated with the occurrence of nasopharyngeal carcinoma (NPC). The latent membrane protein 1 (LMP1) gene, known for its high heterogeneity, plays a crucial role in the oncogenic potential of EBV associated NPC (EBVaNPC). This study aimed to integrate algorithm with experimental validation to contribute valuable insights into the early detection and risk assessment of EBVaNPC, and investigate the functional significance of LMP1 key mutation. The LMP1 region in clinical EBV-positive subjects was sequenced with amplicon-based next-generation sequencing. An automatic viral sequence feature extraction (ViSFE) approach was developed. Biological implications of predicted key mutation on tumor cell biological behaviors were investigated through qRT-PCR, EdU analysis, transwell invasion assay, RNA sequencing and gene ontology fingerprint (GOF) method. Validation results demonstrate the feasibility of ViSFE applied to nucleotide data of varying lengths. Our study identified H101R mutation in LMP1 as a top feature, confirmed by proliferation and invasion experiments. By integrating EBVaNPC GOF and RNA sequencing data, the differentially expressed genes linked to the H101R mutation were primarily involved in immune regulation processes. Both approaches indicated a notable association between FOXP3-T cell anergy and WNT7A-stem cell population maintenance in HNE-1
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.